http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005023828-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee0d662c5a669a873037609d8af9fd8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dda784c93ea5199eef46caff1d78fcfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6576c186ca639261af6a2d47d81c9b08
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
filingDate 2004-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee2cc1ad84b243863ff889238ba12c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e4994d682c20fd5f348c40528821ce9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1744bad322bc02e2999f85ae0c411f7
publicationDate 2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005023828-A1
titleOfInvention Process for producing ribonucleotide or ribonucleotide derivative
abstract A process for producing ribonucleotide or a ribonucleotide derivative from a ribonucleotide derivative having a 2'-hydroxy group protected by a protective group which can be efficiently introduced into the 2'-hydroxy group and causes no steric hindrance in condensation reaction, and which is stably present under the conditions to be used for the removal of a protective group for the 5'-hydroxy group, removal of a protective group for the phosphoric diester group, removal of a protective group for a nuclei acid base, separation of the nucleotide chain from a solid-phase support, etc. but can be removed in a short time under conditions different from these conditions. The process comprises fluorinating a ribonucleotide derivative (II) represented by the following formula (II): (II) or comprises treating the derivative with a tertiary amine in a water-free solvent in the presence of a silylating agent and then hydrolyzing the derivative under neutral or acidic conditions. Thus, a nucleotide or nucleotide derivative from which the 2-hydroxy-protecting group has been removed is produced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10329318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5187189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5878758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008090829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013757-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10428019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016164141-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10167309-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617547-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10724035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10144933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115551805-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115551805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102574888-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695211-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9605019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9744183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10160969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9598458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10322173-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10307434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11608355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007099896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10450568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011034072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590413-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10479995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9394333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007097447-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101426805-B
priorityDate 2003-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0374398-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415795164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467472721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466103277

Total number of triples: 64.